Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.60280348 |
2 | ribosomal small subunit assembly (GO:0000028) | 5.47734805 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.13969067 |
4 | DNA deamination (GO:0045006) | 4.70845600 |
5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.49779377 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.47850502 |
7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.47850502 |
8 | viral transcription (GO:0019083) | 4.33083100 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29245376 |
10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.29013583 |
11 | positive regulation of B cell differentiation (GO:0045579) | 4.22002143 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.16077488 |
13 | translational termination (GO:0006415) | 4.11023514 |
14 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.05567863 |
15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.00547721 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.00208792 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.00208792 |
18 | modulation by symbiont of host immune response (GO:0052553) | 4.00208792 |
19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.00208792 |
20 | modulation by symbiont of host defense response (GO:0052031) | 4.00208792 |
21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.00208792 |
22 | response to peptidoglycan (GO:0032494) | 3.97993092 |
23 | regulation of B cell differentiation (GO:0045577) | 3.97541486 |
24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.89390081 |
25 | translational elongation (GO:0006414) | 3.74990517 |
26 | ribosomal small subunit biogenesis (GO:0042274) | 3.72734674 |
27 | proteasome assembly (GO:0043248) | 3.66937565 |
28 | B cell receptor signaling pathway (GO:0050853) | 3.65726969 |
29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.63930891 |
30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57754482 |
31 | cotranslational protein targeting to membrane (GO:0006613) | 3.57120406 |
32 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.56468533 |
33 | ribosomal large subunit biogenesis (GO:0042273) | 3.56130553 |
34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.55961079 |
35 | protein targeting to ER (GO:0045047) | 3.52035363 |
36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.48317417 |
37 | mature B cell differentiation involved in immune response (GO:0002313) | 3.39500659 |
38 | protein localization to endoplasmic reticulum (GO:0070972) | 3.38155584 |
39 | maturation of SSU-rRNA (GO:0030490) | 3.35682873 |
40 | negative regulation of interleukin-12 production (GO:0032695) | 3.34200775 |
41 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32010980 |
42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.31796077 |
43 | positive thymic T cell selection (GO:0045059) | 3.24975634 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.23194547 |
45 | viral life cycle (GO:0019058) | 3.20662586 |
46 | response to interferon-beta (GO:0035456) | 3.19702037 |
47 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.18424836 |
48 | defense response to protozoan (GO:0042832) | 3.18195786 |
49 | mast cell activation (GO:0045576) | 3.16253892 |
50 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15594085 |
51 | leukocyte aggregation (GO:0070486) | 3.11012913 |
52 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.05614202 |
53 | cellular protein complex disassembly (GO:0043624) | 3.04939951 |
54 | response to type I interferon (GO:0034340) | 3.04891331 |
55 | negative regulation of ligase activity (GO:0051352) | 3.04118183 |
56 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.04118183 |
57 | mature B cell differentiation (GO:0002335) | 3.03691261 |
58 | telomere maintenance via recombination (GO:0000722) | 3.02604668 |
59 | type I interferon signaling pathway (GO:0060337) | 3.02531799 |
60 | cellular response to type I interferon (GO:0071357) | 3.02531799 |
61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.01079744 |
62 | positive regulation of chemokine secretion (GO:0090197) | 3.00930107 |
63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.00824348 |
64 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.99768029 |
65 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98515836 |
66 | detection of other organism (GO:0098543) | 2.97884994 |
67 | T cell homeostasis (GO:0043029) | 2.96580097 |
68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.95278694 |
69 | translational initiation (GO:0006413) | 2.93747151 |
70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.93109292 |
71 | response to interleukin-15 (GO:0070672) | 2.91894010 |
72 | response to protozoan (GO:0001562) | 2.91010966 |
73 | immunoglobulin mediated immune response (GO:0016064) | 2.90740594 |
74 | detection of molecule of bacterial origin (GO:0032490) | 2.90206597 |
75 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.88730871 |
76 | positive regulation of granulocyte differentiation (GO:0030854) | 2.88019773 |
77 | neutrophil activation (GO:0042119) | 2.87785122 |
78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87443454 |
79 | negative regulation of cell killing (GO:0031342) | 2.87443454 |
80 | positive regulation of interferon-alpha production (GO:0032727) | 2.87174109 |
81 | negative thymic T cell selection (GO:0045060) | 2.85966576 |
82 | cellular response to interleukin-15 (GO:0071350) | 2.84607760 |
83 | cellular response to interferon-beta (GO:0035458) | 2.84024306 |
84 | negative T cell selection (GO:0043383) | 2.83477562 |
85 | cellular extravasation (GO:0045123) | 2.82756086 |
86 | chaperone-mediated protein transport (GO:0072321) | 2.81435229 |
87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80542911 |
88 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.78412358 |
89 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78346067 |
90 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77798445 |
91 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.76249000 |
92 | detection of bacterium (GO:0016045) | 2.76058738 |
93 | autophagic vacuole fusion (GO:0000046) | 2.75591563 |
94 | tolerance induction (GO:0002507) | 2.73129641 |
95 | termination of RNA polymerase III transcription (GO:0006386) | 2.72810369 |
96 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.72810369 |
97 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.72619209 |
98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.72619209 |
99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.72619209 |
100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72473083 |
101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72473083 |
102 | response to host immune response (GO:0052572) | 2.72156715 |
103 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72156715 |
104 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.72016942 |
105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.70513488 |
106 | macrophage activation involved in immune response (GO:0002281) | 2.69089478 |
107 | myeloid dendritic cell activation (GO:0001773) | 2.68691187 |
108 | regulation of interferon-alpha production (GO:0032647) | 2.66721699 |
109 | mitotic recombination (GO:0006312) | 2.66137323 |
110 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.65908057 |
111 | detection of external biotic stimulus (GO:0098581) | 2.65116877 |
112 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.64475679 |
113 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.64475679 |
114 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.62841519 |
115 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.62841519 |
116 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.62841519 |
117 | lymph node development (GO:0048535) | 2.62146470 |
118 | platelet dense granule organization (GO:0060155) | 2.61982166 |
119 | regulation of RIG-I signaling pathway (GO:0039535) | 2.61092954 |
120 | B cell mediated immunity (GO:0019724) | 2.60738978 |
121 | positive regulation of macrophage differentiation (GO:0045651) | 2.60022148 |
122 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.60006139 |
123 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.59906122 |
124 | leukocyte degranulation (GO:0043299) | 2.58821663 |
125 | myeloid cell activation involved in immune response (GO:0002275) | 2.58808232 |
126 | granulocyte activation (GO:0036230) | 2.58687745 |
127 | protein complex disassembly (GO:0043241) | 2.58526276 |
128 | nucleoside salvage (GO:0043174) | 2.58349005 |
129 | negative regulation of B cell mediated immunity (GO:0002713) | 2.57117554 |
130 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.57117554 |
131 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.56242482 |
132 | rRNA modification (GO:0000154) | 2.56164102 |
133 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.55423995 |
134 | organelle membrane fusion (GO:0090174) | 2.55032641 |
135 | regulation of mitochondrial translation (GO:0070129) | 2.54755673 |
136 | negative regulation of phagocytosis (GO:0050765) | 2.54342106 |
137 | lymphocyte homeostasis (GO:0002260) | 2.53017316 |
138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52150457 |
139 | response to muramyl dipeptide (GO:0032495) | 2.52102127 |
140 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.51854811 |
141 | ATP synthesis coupled proton transport (GO:0015986) | 2.50895181 |
142 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.50895181 |
143 | establishment of viral latency (GO:0019043) | 2.50870295 |
144 | positive regulation of ligase activity (GO:0051351) | 2.50651051 |
145 | establishment of integrated proviral latency (GO:0075713) | 2.50354590 |
146 | respiratory burst (GO:0045730) | 2.49999713 |
147 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.49644603 |
148 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.49230060 |
149 | mast cell activation involved in immune response (GO:0002279) | 2.49200711 |
150 | mast cell degranulation (GO:0043303) | 2.49200711 |
151 | pyrimidine-containing compound salvage (GO:0008655) | 2.48281732 |
152 | pyrimidine nucleoside salvage (GO:0043097) | 2.48281732 |
153 | negative regulation of humoral immune response (GO:0002921) | 2.48137517 |
154 | leukocyte homeostasis (GO:0001776) | 2.47827114 |
155 | macromolecular complex disassembly (GO:0032984) | 2.46253523 |
156 | DNA strand elongation (GO:0022616) | 2.46172677 |
157 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.45358912 |
158 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.44378871 |
159 | metallo-sulfur cluster assembly (GO:0031163) | 2.44144085 |
160 | iron-sulfur cluster assembly (GO:0016226) | 2.44144085 |
161 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44100732 |
162 | regulation of regulatory T cell differentiation (GO:0045589) | 2.43663879 |
163 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43387237 |
164 | response to host (GO:0075136) | 2.43387237 |
165 | response to host defenses (GO:0052200) | 2.43387237 |
166 | definitive hemopoiesis (GO:0060216) | 2.43260391 |
167 | translation (GO:0006412) | 2.42662860 |
168 | regulation of mast cell degranulation (GO:0043304) | 2.42543332 |
169 | megakaryocyte development (GO:0035855) | 2.41682256 |
170 | regulation of necroptotic process (GO:0060544) | 2.41581187 |
171 | neutrophil activation involved in immune response (GO:0002283) | 2.41291631 |
172 | response to interferon-alpha (GO:0035455) | 2.41071133 |
173 | protein localization to kinetochore (GO:0034501) | 2.40430969 |
174 | negative regulation of B cell apoptotic process (GO:0002903) | 2.40229753 |
175 | positive regulation of chromosome segregation (GO:0051984) | 2.40039664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.97471435 |
2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.52827746 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.45655156 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.05694225 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01682305 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99066953 |
7 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.97107061 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.95358719 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.93643356 |
10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82888927 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.75824176 |
12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.72269427 |
13 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67574102 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.66173177 |
15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64551549 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55379232 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43199206 |
18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27980608 |
19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27656868 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.26984505 |
21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22953543 |
22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.22163437 |
23 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.19319100 |
24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.17900993 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12880518 |
26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11308608 |
27 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.08511834 |
28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05352573 |
29 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.04164250 |
30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98097376 |
31 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97641870 |
32 | * MYC_22102868_ChIP-Seq_BL_Human | 1.95845217 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92923200 |
34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92021329 |
35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.89929792 |
36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86365290 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84567418 |
38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83838821 |
39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82222533 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81735421 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81083344 |
42 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.79768796 |
43 | MYB_26560356_Chip-Seq_TH2_Human | 1.78929900 |
44 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77633483 |
45 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.77037565 |
46 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74677408 |
47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.73789223 |
48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72969640 |
49 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72540916 |
50 | MAF_26560356_Chip-Seq_TH1_Human | 1.70590406 |
51 | MYB_26560356_Chip-Seq_TH1_Human | 1.70494481 |
52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70488879 |
53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66761740 |
54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66618499 |
55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65974316 |
56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65321728 |
57 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57829761 |
58 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.56423022 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55360360 |
60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.54992052 |
61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47540259 |
62 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47456640 |
63 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46577010 |
64 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.46190138 |
65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45006415 |
66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44664082 |
67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.44428164 |
68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42886438 |
69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38603927 |
70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38272587 |
71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37060656 |
72 | MAF_26560356_Chip-Seq_TH2_Human | 1.36745283 |
73 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35577436 |
74 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.34118208 |
75 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33803571 |
76 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31324642 |
77 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30507785 |
78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29045215 |
79 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28996803 |
80 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27383995 |
81 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26331500 |
82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19942186 |
83 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19729715 |
84 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18213186 |
85 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.16743190 |
86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16045143 |
87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15777805 |
88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15514673 |
89 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15003570 |
90 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14437976 |
91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11551260 |
92 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10327870 |
93 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.10193041 |
94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10167145 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10004223 |
96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09933782 |
97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09912626 |
98 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09229113 |
99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09097022 |
100 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05461221 |
101 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04691529 |
102 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03796924 |
103 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03531128 |
104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02612191 |
105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02546076 |
106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02358353 |
107 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01537157 |
108 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99491971 |
109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99438644 |
110 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99261507 |
111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98654858 |
112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97227848 |
113 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.96693220 |
114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96588311 |
115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96582667 |
116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96341651 |
117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94709078 |
118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93931923 |
119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93431163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.90630974 |
2 | MP0005671_abnormal_response_to | 3.77448972 |
3 | MP0002396_abnormal_hematopoietic_system | 3.63745730 |
4 | MP0000685_abnormal_immune_system | 3.46615858 |
5 | MP0003763_abnormal_thymus_physiology | 3.16179745 |
6 | MP0009785_altered_susceptibility_to | 2.98404085 |
7 | MP0001800_abnormal_humoral_immune | 2.97358864 |
8 | MP0002723_abnormal_immune_serum | 2.67118089 |
9 | MP0005464_abnormal_platelet_physiology | 2.62762304 |
10 | MP0002452_abnormal_antigen_presenting | 2.60346622 |
11 | MP0002420_abnormal_adaptive_immunity | 2.57371821 |
12 | MP0001819_abnormal_immune_cell | 2.53819813 |
13 | MP0005025_abnormal_response_to | 2.53721591 |
14 | MP0002277_abnormal_respiratory_mucosa | 2.51425319 |
15 | MP0005000_abnormal_immune_tolerance | 2.49942288 |
16 | MP0002398_abnormal_bone_marrow | 2.40331132 |
17 | MP0001790_abnormal_immune_system | 2.39769770 |
18 | MP0005387_immune_system_phenotype | 2.39769770 |
19 | MP0003436_decreased_susceptibility_to | 2.36192248 |
20 | MP0003724_increased_susceptibility_to | 2.35184307 |
21 | MP0002419_abnormal_innate_immunity | 2.32460710 |
22 | MP0000689_abnormal_spleen_morphology | 2.31499106 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.24293247 |
24 | MP0005075_abnormal_melanosome_morpholog | 2.18265177 |
25 | MP0000716_abnormal_immune_system | 2.17205685 |
26 | MP0006082_CNS_inflammation | 2.13455402 |
27 | MP0003191_abnormal_cellular_cholesterol | 2.11930800 |
28 | MP0002722_abnormal_immune_system | 2.10600268 |
29 | MP0008260_abnormal_autophagy | 2.09016297 |
30 | MP0005058_abnormal_lysosome_morphology | 2.07641880 |
31 | MP0003866_abnormal_defecation | 1.99704354 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.98289688 |
33 | MP0002429_abnormal_blood_cell | 1.90623031 |
34 | MP0003111_abnormal_nucleus_morphology | 1.83123903 |
35 | MP0004808_abnormal_hematopoietic_stem | 1.78720292 |
36 | MP0002405_respiratory_system_inflammati | 1.78609836 |
37 | MP0001873_stomach_inflammation | 1.78374682 |
38 | MP0001853_heart_inflammation | 1.76148730 |
39 | MP0010155_abnormal_intestine_physiology | 1.74792105 |
40 | MP0000465_gastrointestinal_hemorrhage | 1.69030121 |
41 | MP0000703_abnormal_thymus_morphology | 1.68294414 |
42 | MP0001845_abnormal_inflammatory_respons | 1.67822846 |
43 | MP0008469_abnormal_protein_level | 1.63621365 |
44 | MP0005174_abnormal_tail_pigmentation | 1.57254554 |
45 | MP0008058_abnormal_DNA_repair | 1.54388939 |
46 | MP0002166_altered_tumor_susceptibility | 1.54060000 |
47 | MP0004147_increased_porphyrin_level | 1.44834907 |
48 | MP0005451_abnormal_body_composition | 1.44776456 |
49 | MP0001545_abnormal_hematopoietic_system | 1.44448593 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.44448593 |
51 | MP0006035_abnormal_mitochondrial_morpho | 1.44010342 |
52 | MP0003303_peritoneal_inflammation | 1.43151667 |
53 | MP0000490_abnormal_crypts_of | 1.37345126 |
54 | MP0004947_skin_inflammation | 1.32063669 |
55 | MP0008007_abnormal_cellular_replicative | 1.28098960 |
56 | MP0002095_abnormal_skin_pigmentation | 1.27610848 |
57 | MP0001764_abnormal_homeostasis | 1.27547789 |
58 | MP0003172_abnormal_lysosome_physiology | 1.27124167 |
59 | MP0002933_joint_inflammation | 1.20276079 |
60 | MP0003300_gastrointestinal_ulcer | 1.18565857 |
61 | MP0003828_pulmonary_edema | 1.18349181 |
62 | MP0010094_abnormal_chromosome_stability | 1.17433027 |
63 | MP0003195_calcinosis | 1.16786519 |
64 | MP0003693_abnormal_embryo_hatching | 1.14721704 |
65 | MP0001533_abnormal_skeleton_physiology | 1.14698583 |
66 | MP0009379_abnormal_foot_pigmentation | 1.13527668 |
67 | MP0009763_increased_sensitivity_to | 1.11285888 |
68 | MP0002019_abnormal_tumor_incidence | 1.11208743 |
69 | MP0005365_abnormal_bile_salt | 1.10967555 |
70 | MP0002006_tumorigenesis | 1.06155155 |
71 | MP0001986_abnormal_taste_sensitivity | 1.05743894 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.03945850 |
73 | MP0009840_abnormal_foam_cell | 1.03614584 |
74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03038273 |
75 | MP0000858_altered_metastatic_potential | 0.99306923 |
76 | MP0008932_abnormal_embryonic_tissue | 0.97101316 |
77 | MP0000343_altered_response_to | 0.96104085 |
78 | MP0002163_abnormal_gland_morphology | 0.94807566 |
79 | MP0000358_abnormal_cell_content/ | 0.94308085 |
80 | MP0009764_decreased_sensitivity_to | 0.94103412 |
81 | MP0003186_abnormal_redox_activity | 0.93776816 |
82 | MP0009765_abnormal_xenobiotic_induced | 0.93636115 |
83 | MP0000350_abnormal_cell_proliferation | 0.93424109 |
84 | MP0000015_abnormal_ear_pigmentation | 0.90169303 |
85 | MP0002132_abnormal_respiratory_system | 0.88524849 |
86 | MP0003077_abnormal_cell_cycle | 0.88358007 |
87 | MP0003806_abnormal_nucleotide_metabolis | 0.87420273 |
88 | MP0004381_abnormal_hair_follicle | 0.85882699 |
89 | MP0005310_abnormal_salivary_gland | 0.85313419 |
90 | MP0001919_abnormal_reproductive_system | 0.84949492 |
91 | MP0008004_abnormal_stomach_pH | 0.80704341 |
92 | MP0000371_diluted_coat_color | 0.79765353 |
93 | MP0006036_abnormal_mitochondrial_physio | 0.79542694 |
94 | MP0000313_abnormal_cell_death | 0.78579059 |
95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78283777 |
96 | MP0000566_synostosis | 0.77490491 |
97 | MP0008873_increased_physiological_sensi | 0.77379656 |
98 | MP0000609_abnormal_liver_physiology | 0.73383579 |
99 | MP0005085_abnormal_gallbladder_physiolo | 0.73351242 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71338088 |
101 | MP0005083_abnormal_biliary_tract | 0.71288386 |
102 | MP0005381_digestive/alimentary_phenotyp | 0.70929474 |
103 | MP0004883_abnormal_blood_vessel | 0.70591583 |
104 | MP0003718_maternal_effect | 0.70272262 |
105 | MP0008057_abnormal_DNA_replication | 0.69831020 |
106 | MP0000598_abnormal_liver_morphology | 0.69100433 |
107 | MP0002254_reproductive_system_inflammat | 0.68669434 |
108 | MP0003075_altered_response_to | 0.68252445 |
109 | MP0002136_abnormal_kidney_physiology | 0.67664358 |
110 | MP0009278_abnormal_bone_marrow | 0.67077050 |
111 | MP0003786_premature_aging | 0.66918250 |
112 | MP0003448_altered_tumor_morphology | 0.66872121 |
113 | MP0005084_abnormal_gallbladder_morpholo | 0.64692388 |
114 | MP0003252_abnormal_bile_duct | 0.63167271 |
115 | MP0009643_abnormal_urine_homeostasis | 0.62986374 |
116 | MP0005408_hypopigmentation | 0.62960687 |
117 | MP0005023_abnormal_wound_healing | 0.62830209 |
118 | MP0005319_abnormal_enzyme/_coenzyme | 0.62755821 |
119 | MP0001851_eye_inflammation | 0.62450769 |
120 | MP0003183_abnormal_peptide_metabolism | 0.60268740 |
121 | MP0004957_abnormal_blastocyst_morpholog | 0.60195698 |
122 | MP0009642_abnormal_blood_homeostasis | 0.59862161 |
123 | MP0005166_decreased_susceptibility_to | 0.59725006 |
124 | MP0001663_abnormal_digestive_system | 0.57261577 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Panhypogammaglobulinemia (HP:0003139) | 4.26425003 |
2 | Orchitis (HP:0100796) | 4.26097025 |
3 | Retrobulbar optic neuritis (HP:0100654) | 4.14215711 |
4 | Optic neuritis (HP:0100653) | 4.14215711 |
5 | IgM deficiency (HP:0002850) | 4.06680980 |
6 | Recurrent abscess formation (HP:0002722) | 3.99377906 |
7 | Agammaglobulinemia (HP:0004432) | 3.83754955 |
8 | Aplastic anemia (HP:0001915) | 3.76481571 |
9 | Thrombocytosis (HP:0001894) | 3.75034634 |
10 | Chronic otitis media (HP:0000389) | 3.75011816 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69350509 |
12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.64275043 |
13 | Abnormal number of erythroid precursors (HP:0012131) | 3.56223913 |
14 | Recurrent viral infections (HP:0004429) | 3.47670108 |
15 | Vacuolated lymphocytes (HP:0001922) | 3.47455661 |
16 | Recurrent bacterial skin infections (HP:0005406) | 3.45307732 |
17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41343898 |
18 | Abnormality of T cell physiology (HP:0011840) | 3.33358032 |
19 | Recurrent bronchitis (HP:0002837) | 3.30159900 |
20 | Inflammation of the large intestine (HP:0002037) | 3.23070300 |
21 | Recurrent fungal infections (HP:0002841) | 3.20720497 |
22 | Abnormality of T cells (HP:0002843) | 3.20094946 |
23 | Eczematoid dermatitis (HP:0000976) | 3.18260448 |
24 | Colitis (HP:0002583) | 3.11563255 |
25 | Acute necrotizing encephalopathy (HP:0006965) | 3.09865300 |
26 | Reticulocytopenia (HP:0001896) | 3.09274971 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 3.06287214 |
28 | Gastrointestinal inflammation (HP:0004386) | 3.05191167 |
29 | Recurrent skin infections (HP:0001581) | 3.02968454 |
30 | Progressive muscle weakness (HP:0003323) | 3.01381841 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00739046 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00739046 |
33 | Mitochondrial inheritance (HP:0001427) | 2.99441083 |
34 | Myositis (HP:0100614) | 2.97756884 |
35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.97526062 |
36 | Meningitis (HP:0001287) | 2.91805063 |
37 | Lymphopenia (HP:0001888) | 2.90126227 |
38 | Keratoconjunctivitis (HP:0001096) | 2.86659095 |
39 | Severe combined immunodeficiency (HP:0004430) | 2.86121458 |
40 | IgG deficiency (HP:0004315) | 2.79945659 |
41 | Prolonged bleeding time (HP:0003010) | 2.78674934 |
42 | Chronic diarrhea (HP:0002028) | 2.78231411 |
43 | Epistaxis (HP:0000421) | 2.77351170 |
44 | Anorexia (HP:0002039) | 2.77284908 |
45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.76787263 |
46 | B lymphocytopenia (HP:0010976) | 2.72831522 |
47 | Abnormality of B cell number (HP:0010975) | 2.72831522 |
48 | Cellulitis (HP:0100658) | 2.72505226 |
49 | Granulocytopenia (HP:0001913) | 2.70550707 |
50 | T lymphocytopenia (HP:0005403) | 2.66624839 |
51 | Acute encephalopathy (HP:0006846) | 2.64613969 |
52 | Increased CSF lactate (HP:0002490) | 2.63651110 |
53 | Hypoplasia of the thymus (HP:0000778) | 2.61727089 |
54 | Recurrent sinusitis (HP:0011108) | 2.58197297 |
55 | Petechiae (HP:0000967) | 2.58193912 |
56 | Combined immunodeficiency (HP:0005387) | 2.57942231 |
57 | Abnormality of T cell number (HP:0011839) | 2.57741000 |
58 | Gastrointestinal infarctions (HP:0005244) | 2.55236266 |
59 | Hepatocellular necrosis (HP:0001404) | 2.52710741 |
60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.52472208 |
61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.52472208 |
62 | Gastrointestinal stroma tumor (HP:0100723) | 2.51799863 |
63 | Respiratory difficulties (HP:0002880) | 2.51313750 |
64 | Urticaria (HP:0001025) | 2.50784334 |
65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.49162463 |
66 | Type I transferrin isoform profile (HP:0003642) | 2.47310848 |
67 | Abnormality of the nasal mucosa (HP:0000433) | 2.47062544 |
68 | Nasal polyposis (HP:0100582) | 2.46154574 |
69 | Increased hepatocellular lipid droplets (HP:0006565) | 2.45221622 |
70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.44950407 |
71 | Abnormality of macrophages (HP:0004311) | 2.44684250 |
72 | Lymphoma (HP:0002665) | 2.44537641 |
73 | Hypochromic microcytic anemia (HP:0004840) | 2.44347908 |
74 | Macrocytic anemia (HP:0001972) | 2.43139954 |
75 | Progressive macrocephaly (HP:0004481) | 2.41562346 |
76 | Encephalitis (HP:0002383) | 2.39963788 |
77 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39438765 |
78 | Poikiloderma (HP:0001029) | 2.34881889 |
79 | Pancytopenia (HP:0001876) | 2.34717737 |
80 | Renal Fanconi syndrome (HP:0001994) | 2.34411161 |
81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32832977 |
82 | Abnormality of eosinophils (HP:0001879) | 2.32187339 |
83 | Hyperalaninemia (HP:0003348) | 2.32112875 |
84 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32112875 |
85 | Abnormality of alanine metabolism (HP:0010916) | 2.32112875 |
86 | Stomatitis (HP:0010280) | 2.31519668 |
87 | Eosinophilia (HP:0001880) | 2.29698545 |
88 | Duplicated collecting system (HP:0000081) | 2.29669152 |
89 | Neutropenia (HP:0001875) | 2.29595637 |
90 | Pallor (HP:0000980) | 2.29002314 |
91 | Pustule (HP:0200039) | 2.28684119 |
92 | Lactic acidosis (HP:0003128) | 2.26397417 |
93 | Increased IgM level (HP:0003496) | 2.25512359 |
94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25283322 |
95 | Impaired platelet aggregation (HP:0003540) | 2.25013340 |
96 | Abnormal platelet function (HP:0011869) | 2.25013340 |
97 | Thyroid-stimulating hormone excess (HP:0002925) | 2.24468996 |
98 | Hepatic necrosis (HP:0002605) | 2.22534388 |
99 | Hypochromic anemia (HP:0001931) | 2.20813963 |
100 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20753906 |
101 | Arterial thrombosis (HP:0004420) | 2.19906903 |
102 | Purpura (HP:0000979) | 2.19825791 |
103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19806174 |
104 | Obstructive lung disease (HP:0006536) | 2.19806174 |
105 | Long foot (HP:0001833) | 2.19369868 |
106 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18430113 |
107 | Spontaneous hematomas (HP:0007420) | 2.18120285 |
108 | Entropion (HP:0000621) | 2.17383981 |
109 | Vasculitis (HP:0002633) | 2.16453206 |
110 | Microcytic anemia (HP:0001935) | 2.16139643 |
111 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13254375 |
112 | Systemic lupus erythematosus (HP:0002725) | 2.11483937 |
113 | Leukocytosis (HP:0001974) | 2.11432122 |
114 | Increased serum lactate (HP:0002151) | 2.10089959 |
115 | Thyroiditis (HP:0100646) | 2.09384221 |
116 | Mediastinal lymphadenopathy (HP:0100721) | 2.08123299 |
117 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.08002733 |
118 | Exercise intolerance (HP:0003546) | 2.07568358 |
119 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.06363923 |
120 | Gangrene (HP:0100758) | 2.05453242 |
121 | Glomerulonephritis (HP:0000099) | 2.05436186 |
122 | Pulmonary fibrosis (HP:0002206) | 2.05140391 |
123 | Abnormality of the renal collecting system (HP:0004742) | 2.05109246 |
124 | Reduced antithrombin III activity (HP:0001976) | 2.04062415 |
125 | Autoimmune hemolytic anemia (HP:0001890) | 2.03569661 |
126 | Hypertensive crisis (HP:0100735) | 2.02306864 |
127 | Microvesicular hepatic steatosis (HP:0001414) | 2.01658882 |
128 | Increased IgE level (HP:0003212) | 2.01625621 |
129 | Exertional dyspnea (HP:0002875) | 2.00296231 |
130 | Polyneuropathy (HP:0001271) | 1.99781942 |
131 | Hemoptysis (HP:0002105) | 1.97405744 |
132 | Oral leukoplakia (HP:0002745) | 1.97150604 |
133 | Generalized aminoaciduria (HP:0002909) | 1.96246166 |
134 | Cleft eyelid (HP:0000625) | 1.96225068 |
135 | Abnormality of the prostate (HP:0008775) | 1.95308959 |
136 | Skin rash (HP:0000988) | 1.95163937 |
137 | Acute hepatic failure (HP:0006554) | 1.94377216 |
138 | Cerebral edema (HP:0002181) | 1.93694694 |
139 | Increased muscle lipid content (HP:0009058) | 1.92806673 |
140 | Increased cerebral lipofuscin (HP:0011813) | 1.92068212 |
141 | Abnormal protein glycosylation (HP:0012346) | 1.91966207 |
142 | Abnormal glycosylation (HP:0012345) | 1.91966207 |
143 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.91966207 |
144 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.91966207 |
145 | IgA deficiency (HP:0002720) | 1.90304723 |
146 | Progressive neurologic deterioration (HP:0002344) | 1.89755916 |
147 | Dry hair (HP:0011359) | 1.89600132 |
148 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88938427 |
149 | Bronchitis (HP:0012387) | 1.88846924 |
150 | Thoracic kyphosis (HP:0002942) | 1.88630543 |
151 | Hepatosplenomegaly (HP:0001433) | 1.88271082 |
152 | Episodic fever (HP:0001954) | 1.85203845 |
153 | Gingivitis (HP:0000230) | 1.85176317 |
154 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.82218215 |
155 | Premature loss of primary teeth (HP:0006323) | 1.81166143 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.33297979 |
2 | MKNK2 | 4.27111025 |
3 | VRK2 | 3.65911029 |
4 | TAOK2 | 3.34837732 |
5 | TAOK1 | 3.23798758 |
6 | KIT | 3.12221535 |
7 | MAP3K11 | 2.91208295 |
8 | MKNK1 | 2.87308939 |
9 | MAP3K3 | 2.72081182 |
10 | ZAP70 | 2.67539914 |
11 | TXK | 2.53990382 |
12 | MAP2K3 | 2.47891885 |
13 | CSF1R | 2.44617930 |
14 | TNIK | 2.35393733 |
15 | MAPKAPK3 | 2.27857333 |
16 | BTK | 2.23893172 |
17 | TEC | 2.22351320 |
18 | IKBKE | 2.18554165 |
19 | TGFBR2 | 2.14276276 |
20 | FLT3 | 2.13969431 |
21 | TBK1 | 2.12045123 |
22 | TYK2 | 2.03751856 |
23 | BLK | 2.01475067 |
24 | EEF2K | 1.94919639 |
25 | KDR | 1.87829174 |
26 | NME2 | 1.86931884 |
27 | IRAK4 | 1.83692479 |
28 | STK16 | 1.71227235 |
29 | BCKDK | 1.68993038 |
30 | SYK | 1.63068365 |
31 | ITK | 1.61170300 |
32 | NME1 | 1.59732882 |
33 | NLK | 1.54899527 |
34 | JAK3 | 1.52804663 |
35 | MAP3K6 | 1.52565943 |
36 | IKBKB | 1.48414747 |
37 | LCK | 1.42570886 |
38 | EIF2AK3 | 1.39596172 |
39 | STK10 | 1.36077517 |
40 | ERN1 | 1.35300950 |
41 | WEE1 | 1.34796554 |
42 | LYN | 1.30190996 |
43 | TNK2 | 1.28393342 |
44 | SMG1 | 1.23457927 |
45 | PIM2 | 1.22520845 |
46 | ADRBK2 | 1.20096661 |
47 | FES | 1.19387222 |
48 | CCNB1 | 1.18037213 |
49 | MAP2K6 | 1.17881679 |
50 | MAPK12 | 1.17261019 |
51 | RPS6KB2 | 1.15755543 |
52 | ZAK | 1.14852515 |
53 | PDK2 | 1.12741042 |
54 | FGFR4 | 1.10722043 |
55 | TAF1 | 1.09975571 |
56 | MAP3K1 | 1.09391005 |
57 | GRK6 | 1.09090412 |
58 | MAPKAPK5 | 1.05701994 |
59 | TESK2 | 1.04183070 |
60 | STK4 | 1.03743081 |
61 | MARK3 | 1.03230618 |
62 | MAP3K14 | 1.01906415 |
63 | CDK19 | 1.00202643 |
64 | TTK | 0.97794949 |
65 | MST4 | 0.97786434 |
66 | JAK1 | 0.96319138 |
67 | ABL2 | 0.95704929 |
68 | EPHB1 | 0.95136690 |
69 | CSK | 0.94724175 |
70 | MAP3K12 | 0.93163040 |
71 | MATK | 0.92822510 |
72 | CDC7 | 0.92681418 |
73 | MAP3K13 | 0.91002706 |
74 | MUSK | 0.90587453 |
75 | MAP3K5 | 0.90256851 |
76 | FGR | 0.90177585 |
77 | BUB1 | 0.89923854 |
78 | PBK | 0.89522581 |
79 | IRAK3 | 0.88834987 |
80 | PRPF4B | 0.86095383 |
81 | HCK | 0.86094589 |
82 | VRK1 | 0.84972541 |
83 | RPS6KA4 | 0.84962354 |
84 | MAP3K8 | 0.84291105 |
85 | SIK3 | 0.83465226 |
86 | LRRK2 | 0.82577352 |
87 | TGFBR1 | 0.79361971 |
88 | CDK3 | 0.77489757 |
89 | MAP3K10 | 0.77445337 |
90 | BRSK2 | 0.76398471 |
91 | IRAK2 | 0.74649238 |
92 | TSSK6 | 0.74187584 |
93 | CHEK2 | 0.73544418 |
94 | PIM1 | 0.71392975 |
95 | PAK4 | 0.68183422 |
96 | PLK3 | 0.67623725 |
97 | CDK8 | 0.67287231 |
98 | MAPK15 | 0.64289303 |
99 | CAMKK2 | 0.64260987 |
100 | MAP2K7 | 0.63001812 |
101 | TAOK3 | 0.60909954 |
102 | GRK7 | 0.60526902 |
103 | TRPM7 | 0.60273584 |
104 | MAPK7 | 0.59404504 |
105 | MAPK11 | 0.58527228 |
106 | PRKCQ | 0.54966918 |
107 | STK24 | 0.54639995 |
108 | EIF2AK2 | 0.53793739 |
109 | DYRK3 | 0.52139049 |
110 | CLK1 | 0.52133079 |
111 | MAPK4 | 0.51625764 |
112 | CSNK1G3 | 0.50559189 |
113 | ACVR1B | 0.50032113 |
114 | MYLK | 0.49478803 |
115 | PLK4 | 0.49380799 |
116 | EIF2AK1 | 0.49361238 |
117 | DAPK1 | 0.48384167 |
118 | CDK7 | 0.47351603 |
119 | ALK | 0.45873978 |
120 | PLK1 | 0.42250981 |
121 | NEK9 | 0.41912175 |
122 | RIPK4 | 0.41479023 |
123 | CDK4 | 0.41079023 |
124 | JAK2 | 0.41075772 |
125 | MAPKAPK2 | 0.40602493 |
126 | PASK | 0.39759564 |
127 | IGF1R | 0.39410152 |
128 | TLK1 | 0.38797700 |
129 | AURKB | 0.38663415 |
130 | ATR | 0.37656996 |
131 | IRAK1 | 0.37645580 |
132 | NEK1 | 0.37557783 |
133 | CHUK | 0.35865466 |
134 | CSNK1G1 | 0.35160417 |
135 | ARAF | 0.34842533 |
136 | AURKA | 0.34603985 |
137 | CSNK2A2 | 0.34163481 |
138 | RAF1 | 0.34028194 |
139 | MAP3K7 | 0.34017988 |
140 | CSNK2A1 | 0.33305422 |
141 | SRPK1 | 0.32468328 |
142 | NUAK1 | 0.32439918 |
143 | BRSK1 | 0.31917486 |
144 | PRKG2 | 0.31868341 |
145 | SIK2 | 0.31135695 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.01818416 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.95493699 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.05386394 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.52749383 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.49619703 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.27108003 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 2.26688637 |
8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.21040134 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.12477632 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.09884069 |
11 | Base excision repair_Homo sapiens_hsa03410 | 2.01865757 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97669371 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94880091 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82960183 |
15 | Measles_Homo sapiens_hsa05162 | 1.81735753 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81560802 |
17 | Proteasome_Homo sapiens_hsa03050 | 1.81082624 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77030647 |
19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.73280852 |
20 | RNA polymerase_Homo sapiens_hsa03020 | 1.71579731 |
21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69713470 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66937421 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66400810 |
24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62537248 |
25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60684536 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59164872 |
27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57416173 |
28 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46884883 |
29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44176749 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37469260 |
31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33682812 |
32 | Spliceosome_Homo sapiens_hsa03040 | 1.29936867 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24691116 |
34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22786542 |
35 | Allograft rejection_Homo sapiens_hsa05330 | 1.22563424 |
36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21867709 |
37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21425195 |
38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21233157 |
39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.14521155 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.13640220 |
41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12167910 |
42 | Protein export_Homo sapiens_hsa03060 | 1.12092502 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.11763203 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09336983 |
45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08862277 |
46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08030601 |
47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07776715 |
48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05638762 |
49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04162945 |
50 | Cell cycle_Homo sapiens_hsa04110 | 1.02282216 |
51 | Shigellosis_Homo sapiens_hsa05131 | 0.98952622 |
52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98730579 |
53 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95645237 |
54 | Influenza A_Homo sapiens_hsa05164 | 0.94735220 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94305251 |
56 | ABC transporters_Homo sapiens_hsa02010 | 0.93461860 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90798523 |
58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88412075 |
59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88112277 |
60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87985730 |
61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87748236 |
62 | RNA degradation_Homo sapiens_hsa03018 | 0.86471092 |
63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86043513 |
64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84960217 |
65 | Apoptosis_Homo sapiens_hsa04210 | 0.83391232 |
66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83127343 |
67 | Lysosome_Homo sapiens_hsa04142 | 0.81442655 |
68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80834205 |
69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80707703 |
70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78081886 |
71 | Purine metabolism_Homo sapiens_hsa00230 | 0.77211077 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76260418 |
73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75947578 |
74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75093408 |
75 | Platelet activation_Homo sapiens_hsa04611 | 0.72340159 |
76 | Tuberculosis_Homo sapiens_hsa05152 | 0.70515632 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70274251 |
78 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69996173 |
79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69671509 |
80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69585172 |
81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65448112 |
82 | Malaria_Homo sapiens_hsa05144 | 0.65048941 |
83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64342989 |
84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63417386 |
85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61889905 |
86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60023540 |
87 | Hepatitis C_Homo sapiens_hsa05160 | 0.59809149 |
88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58984544 |
89 | RNA transport_Homo sapiens_hsa03013 | 0.58631904 |
90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58445167 |
91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58235436 |
92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57472249 |
93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57175580 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56999948 |
95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54626234 |
96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54350265 |
97 | Hepatitis B_Homo sapiens_hsa05161 | 0.53848864 |
98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53735500 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51904525 |
100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51069451 |
101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49852270 |
102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48491995 |
103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47878798 |
104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47514550 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46797643 |
106 | Phagosome_Homo sapiens_hsa04145 | 0.46240785 |
107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45923532 |
108 | Salmonella infection_Homo sapiens_hsa05132 | 0.45779005 |
109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45510907 |
110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45074252 |
111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43769817 |
112 | Peroxisome_Homo sapiens_hsa04146 | 0.43493748 |
113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43032652 |
114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40761442 |
115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40632367 |
116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40450112 |
117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40055768 |
118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38644191 |
119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34773105 |
120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34282724 |
121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32926760 |
122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32594899 |
123 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.32338930 |
124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31875003 |
125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31400040 |
126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29550071 |